These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22473596)

  • 21. Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study.
    Kamphuisen PW; Lee AYY; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    J Thromb Haemost; 2018 Jun; 16(6):1069-1077. PubMed ID: 29573330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials Group.
    Le Maître A; Ding K; Shepherd FA; Leighl N; Arnold A; Seymour L;
    J Thorac Oncol; 2009 May; 4(5):586-94. PubMed ID: 19357539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
    Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
    J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study.
    Francis CW; Kessler CM; Goldhaber SZ; Kovacs MJ; Monreal M; Huisman MV; Bergqvist D; Turpie AG; Ortel TL; Spyropoulos AC; Pabinger I; Kakkar AK
    J Thromb Haemost; 2015 Jun; 13(6):1028-35. PubMed ID: 25827941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parenteral anticoagulation in ambulatory patients with cancer.
    Akl EA; Kahale LA; Ballout RA; Barba M; Yosuico VE; van Doormaal FF; Middeldorp S; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2014 Dec; (12):CD006652. PubMed ID: 25491949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous thromboembolism in lymphoma: how effectively are we treating patients?
    Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Daw HA
    Am J Clin Oncol; 2009 Oct; 32(5):521-3. PubMed ID: 19546801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
    Douketis JD; Spyropoulos AC; Kaatz S; Becker RC; Caprini JA; Dunn AS; Garcia DA; Jacobson A; Jaffer AK; Kong DF; Schulman S; Turpie AG; Hasselblad V; Ortel TL;
    N Engl J Med; 2015 Aug; 373(9):823-33. PubMed ID: 26095867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
    Schulman S; Kakkar AK; Goldhaber SZ; Schellong S; Eriksson H; Mismetti P; Christiansen AV; Friedman J; Le Maulf F; Peter N; Kearon C;
    Circulation; 2014 Feb; 129(7):764-72. PubMed ID: 24344086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parenteral anticoagulation in ambulatory patients with cancer.
    Akl EA; Kahale LA; Hakoum MB; Matar CF; Sperati F; Barba M; Yosuico VED; Terrenato I; Synnot A; Schünemann H
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006652. PubMed ID: 28892556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience.
    Moruf A; Spyropoulos AC; Schardt TQ; Gibson E; Manco-Johnson MJ; Wang M; Goldenberg NA
    Thromb Res; 2012 Oct; 130(4):612-5. PubMed ID: 22749329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of Venous Thromboembolism in Patients With Cancer Treated With Warfarin.
    Marshall AL; Campigotto F; Neuberg D; Rowe B; Connors JM
    Clin Appl Thromb Hemost; 2015 Oct; 21(7):632-8. PubMed ID: 25850917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
    Bauersachs R; Lee AYY; Kamphuisen PW; Meyer G; Janas MS; Jarner MF; Khorana AA;
    Thromb Haemost; 2018 May; 118(5):914-921. PubMed ID: 29618162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2011 Apr; (4):CD006652. PubMed ID: 21491396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center.
    Labrador J; González-Rivero J; Monroy R; Lozano FS; López-Corral L; Caballero MD; Bastida JM; González-Porras JR
    Thromb Res; 2016 Jun; 142():52-6. PubMed ID: 26922092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation.
    Khorana AA; McCrae K; Milentijevic D; McCormick N; Laliberté F; Crivera C; Lefebvre P; Lejeune D; Rozjabek H; Schein J; Streiff MB
    Am J Hematol; 2019 Feb; 94(2):E58-E61. PubMed ID: 30474161
    [No Abstract]   [Full Text] [Related]  

  • 37. Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer.
    Aziz J; Wang TF; Siegal D; Douketis J; Le Gal G; Carrier M; Shaw JR
    J Thromb Haemost; 2023 Apr; 21(4):933-943. PubMed ID: 36696183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome.
    Medjeral-Thomas N; Ziaj S; Condon M; Galliford J; Levy J; Cairns T; Griffith M
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):478-83. PubMed ID: 24334865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006652. PubMed ID: 21249680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.